XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. WYFI
6. STUB
7. EAT
8. BTGO
9. NVDA
10. ARX

Go back to XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Xyratex, Ltd. (NASDAQ: XRTX) Delayed: 2.19 +0.03 (1.39%)
Previous Close $2.16    52 Week High $13.52 
Open $2.22    52 Week Low $8.94 
Day High $2.28    P/E N/A 
Day Low $2.19    EPS $-0.27 
Volume 2,194       

Xyratex, Ltd. (NASDAQ: XRTX) Delayed: 2.19 +0.03 (1.39%)
Previous Close $2.16    52 Week High $13.52 
Open $2.22    52 Week Low $8.94 
Day High $2.28    P/E N/A 
Day Low $2.19    EPS $-0.27 
Volume 2,194